Cargando…

158 Hepatitis C Treatment Update: Current Status and Future Direcctions

Hepatitis C virus infection is a major cause of liver disease, with 170 million persons infected worldwide. Hepatitis C virus is a ssRNA virus that preferentially infects human hepatocytes. Approximately 80% of HCV infections progress to chronicity, with development of hepatic fibrosis over time wit...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kottilil, Shyam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149650/ http://dx.doi.org/10.1097/01.qai.0000446742.08719.24

Ejemplares similares

159 Hepatitis B Treatment Update: Current Status and Future Directions
por: Talwani, Rohit
Publicado: (2014)

Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study
por: Salholz-Hillel, Maia, et al.
Publicado: (2023)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

298. Collocation of Hepatitis C Care Continuum with MAT for High-Prevalence, High-Risk Population
por: Narayanan, Shivakumar, et al.
Publicado: (2019)

1236. Baseline liver stiffness and alanine transaminase predicts reduction in liver stiffness in people with chronic hepatitis B on tenofovir alafenamide
por: Tang, Lydia, et al.
Publicado: (2022)

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
por: Chaudhury, Chloe, et al.
Publicado: (2017)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study
por: Salholz-Hillel, Maia, et al.
Publicado: (2021)

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

Systemic manifestations of hepatitis C infection
por: Tang, Lydia, et al.
Publicado: (2016)

Current status and future directions in the management of chronic hepatitis C
por: Aman, Wosen, et al.
Publicado: (2012)

Hepatitis C Treatment: current and future perspectives
por: Munir, Saira, et al.
Publicado: (2010)

Status report on expt. S158
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1979)

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
por: Khanam, Arshi, et al.
Publicado: (2021)

Research Status of the Orphan G Protein Coupled Receptor 158 and Future Perspectives
por: Fu, Xianan, et al.
Publicado: (2022)

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020)

Update on Novel Non-Operative Treatment for Osteoarthritis: Current Status and Future Trends
por: Chen, Tao, et al.
Publicado: (2021)

Current and future strategies for the treatment of chronic hepatitis C
por: Alshuwaykh, Omar, et al.
Publicado: (2021)

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014)

1102. Pediatric Hepatitis C Screening by Maternal Hepatitis C Viral Load Status in Pregnancy
por: DiNicola, Julia, et al.
Publicado: (2023)

2072. Of Mice and Men: HIV-induced CD38 expression on CD8+ T lymphocytes contributes to mitochondrial dysfunction and chronic inflammation despite antiretroviral therapy
por: Mathur, Poonam, et al.
Publicado: (2022)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

Kidney exchange transplantation current status, an update and future perspectives
por: Kute, Vivek B, et al.
Publicado: (2018)

Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C
por: Mania, Anna, et al.
Publicado: (2017)

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
por: Wellington, Jennifer, et al.
Publicado: (2021)

Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020)

F158. FUNCTIONAL CONNECTIVITY DIVERSITY OF THE INSULA CORTEX IN SCHIZOPHRENIA: SUBREGIONS OR CONTINUA?
por: Tian, Ye, et al.
Publicado: (2018)

Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018)

SS-2 Current status and future perspective of radiomics in glioma imaging
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Tickling the TLR7 to cure viral hepatitis
por: Funk, Emily, et al.
Publicado: (2014)

Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions
por: Czaja, Albert J.
Publicado: (2016)

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
por: Suraweera, Duminda, et al.
Publicado: (2016)

PM446. The relationship between MMN and COMT Val108/158Met genotype in schizophrenia
por: Horikoshi, Sho, et al.
Publicado: (2016)

158. The Effect of Insurance Coverage on Appropriate Selection of Hospital Discharge Antibiotics for Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2018)

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
por: Tang, Lydia Shuk Yee, et al.
Publicado: (2016)

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST
por: Tangmose, Karen, et al.
Publicado: (2018)

Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function
por: Orr, Cody, et al.
Publicado: (2021)

On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case Series
por: Bean, Madelyne, et al.
Publicado: (2016)

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C
por: Katsounas, Antonios, et al.
Publicado: (2012)

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
por: Meissner, Eric G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gt8bc14pt7f73g2ohmj0ufrftn